Evidence map›Paper›PMID 42713434›Full record

ArticleFrontiers in microbiology2026

Antimicrobial susceptibility patterns of commensal fecal bacteria isolated from pigs with an intentional genomic alteration that included the selectable marker gene

Tessa E LeCuyer, Jeffrey Monahan, Kayla Farrell, Kent Adams, Anneke Walters, Diamond McClendon, Alexandra Fox, John R Bianchi

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tessa E LeCuyerDepartment of Pathology, Microbiology, and Immunology, UC Davis Weill School of Veterinary Medicine, UC Davis, Davis, CA, United States.
Jeffrey MonahanUnited Therapeutics Corporation, Department of Xeno R&D, Blacksburg, VA, United States.
Kayla FarrellUnited Therapeutics Corporation, Department of Xeno R&D, Blacksburg, VA, United States.
Kent AdamsUnited Therapeutics Corporation, Department of Xeno R&D, Blacksburg, VA, United States.
Anneke WaltersUnited Therapeutics Corporation, Department of Xeno R&D, Blacksburg, VA, United States.
Diamond McClendonVirginia Tech Animal Laboratory Services, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA, United States.
Alexandra FoxVirginia Tech Animal Laboratory Services, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA, United States.
John R BianchiUnited Therapeutics Corporation, Department of Xeno R&D, Blacksburg, VA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Animals with intentional genomic alterations (IGAs) hold promise for meeting increasing worldwide demand for animal-source proteins. As part of regulatory risk assessment for introducing animals with IGAs into the food chain, monitoring commensal bacterial microbiota is recommended due to concern that antimicrobial resistance genes used during IGA selection could be transferred, via horizontal gene transfer, to gastrointestinal or environmental bacterial populations, potentially contributing to antimicrobial resistance. The objective of this study was to assess the antimicrobial susceptibility patterns in commensal bacteria isolated from fecal samples of GalSafe™ pigs that have an IGA that includes the aminoglycoside resistance gene Methods: Antimicrobial resistance rates observed in Results: In total, 137 bacterial isolates recovered from 55 fecal samples collected from 47 individual adult GalSafe™ pigs were evaluated. Prevalence of antimicrobial resistance in GalSafe™ pigs was generally similar to, or lower than, resistance prevalence reported from conventional pigs at slaughter, based on National Antimicrobial Resistance Monitoring System (NARMS) data. Higher resistance rates in GalSafe™ pigs were observed only for quinolones in Discussion: We did not detect evidence of

Indexed as

alpha-galantibiotic resistanceantimicrobial resistance (AMR)genetically engineered animalsNARMS

Identifiers

PMID42713434
PMCPMC13552116

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.